CORT
Corcept Therapeutics Incorporated · Healthcare
Chief Development Officer William Guyer sold $419K of Corcept Therapeutics Incorporated
Sold$418,562
$113.12Price
3,700Shares
−48%Stake
What CORT did after the filing
- The stock from Fri, Aug 7 open, $108.25
- +8.6%
- S&P 500, same days
- +0.3%
Measured over 30 trading days, to the Sep 22 close.
Traded Tue, Aug 4. Filed Thu, Aug 6, 6:44 PM ET, after the close. Returns use the Aug 7 open and the Sep 22 close. Not investment advice.